Vivesto develops drugs for difficult-to-treat cancer from early research to the clinic. The project portfolio consists of the cancer programs Cantrixil, Docetaxel micellar, and the veterinary oncology program Paccal Vet.
Vivesto
Vivesto is a research and development company that develops new treatment options for patients suffering from difficult-to-treat cancer.
